Journal of Cardiovascular Pharmacology · 2013 · 35 citations · 39 references
Veterinary MedicineCardiologyPharmacologyCardiovascular PharmacotherapyInflammationPreventive CardiologyBlood Pressure ManagementCardiovascular DiseaseEndothelial ActivationEndothelial DysfunctionHypertension ManagementHypertensive Heart DiseaseAntihypertensive Drug TherapyAntihypertensive TreatmentArterial ComplianceArterial StiffnessBlood PressureEndothelial Activation MarkersVascular Endothelial FunctionVascular Function In Hypertension
We assessed the contribution of blood pressure (BP), inflammation, and endothelial activation to the development of structural vascular and cardiac changes in hypertension. Furthermore, the effects of antihypertensive therapy were studied. We studied 114 patients with hypertension and left ventricular hypertrophy and 38 matched hypertensive subjects without cardiac hypertrophy and 38 normotensive subjects. The group with hypertension and cardiac hypertrophy were randomized to treatment with an angiotensin receptor blocker (irbesartan) or a beta-adrenergic receptor blocker (atenolol) for 48 weeks. Markers of inflammation (high-sensitive C-reactive protein, interleukin-6, leukocyte counts), vascular function (ambulatory aortic stiffness index, arterial compliance, and pulse pressure), and endothelial activation (E-selectin, intracellular adhesion molecule-1, vascular adhesion molecule-1) were assessed. Markers of inflammation and arterial stiffness were lowest in the normotensive group and highest in patients with hypertensive heart disease; endothelial markers were similar between groups. Inflammation was independently related to BP. Markers of arterial stiffness were independently related to BP and to a lesser extent to left ventricular mass. Antihypertensive treatment improved arterial compliance; inflammatory and endothelial markers remained unchanged. In conclusion, markers of inflammation and arterial stiffness are independently related to BP. Antihypertensive therapy seems to improve arterial stiffness, but effects on markers of inflammation and endothelial activation are small.
39
Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients
Francesco Perticone, Roberto Ceravolo, Arturo Pujia et al. · Circulation · 2001 · 1.1K citations · Full text
Medicine, Cardiology, Pharmacology +17
Blood Pressure and Inflammation in Apparently Healthy Men
Claudia U. Chae, Richard Lee, Nader Rifai et al. · Hypertension · 2001 · 716 citations · Full text
Ambulatory Arterial Stiffness Index Derived From 24-Hour Ambulatory Blood Pressure Monitoring
Yan Li, Ji‐Guang Wang, Eamon Dolan et al. · Hypertension · 2006 · 368 citations · Full text
Medicine, Cardiology, Physiology +15